Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of switching to DuoTrav in patients uncontrolled on bimatoprost/timolol
2010-021973-35Phase 4Completed
- Sponsor
- Alcon Inc.
- Start
- Jul 2010
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of travoprost in open-angle glaucoma (OAG), ocular hypertension and pigmentary glaucoma (PG), sponsored by Alcon Inc. Started Jul 2010; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertensionpigmentary glaucoma (PG)
Beyond the preview
Go deeper on 2010-021973-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-021973-35.